<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied the prevalence and clinical significance of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (ab) in 28 patients affected with well-defined <z:e sem="disease" ids="C0026272" disease_type="Disease or Syndrome" abbrv="MCTD">mixed connective tissue disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Forty-two patients affected with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and 60 healthy subjects were also evaluated, as controls </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e> the prevalence of anticardiolipin (aCL) ab was: IgG high level 17.8% (p less than 0.01 versus healthy controls), IgG low level 7.1% and IgM high level 7.1% </plain></SENT>
<SENT sid="3" pm="."><plain>No patients had low level of aCL IgM, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> or false positive VDRL </plain></SENT>
<SENT sid="4" pm="."><plain>The aCL profile was similar to that found in SLE patients, but in SLE <z:hpo ids='HP_0000001'>all</z:hpo> prevalences were higher than in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e> patients the aCL ab were correlated with <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> but not with <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> and/or abortions </plain></SENT>
</text></document>